Diclofenac Sodium
Product Images NDC 45865-999

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 45865-999). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (999)

Diclofenac Sodium Delayed Release Tablets 50 mg packaging label from Medsource Pharmaceuticals. The label indicates the product is generic for Voltaren, with directions to take with food to prevent stomach upset and dosage instructions to be filled in. The label includes the NDC 45565-0999-30 and mentions tablets are white, round, and coated. The label shows peel-and-read instructions on the right side.*

FDA Label Image

Figure (Dic05 0006 01)

Chemical structure of Diclofenac sodium, showing two chlorinated aromatic rings and a carboxylate sodium group, consistent with the active ingredient in Diclofenac Sodium Delayed Release tablets.*

FDA Label Image

Figure (Dic05 0006 02)

Diclofenac Sodium Delayed Release tablets packaged in a white and light blue blister card. The packaging indicates that it is manufactured by Medsource Pharmaceuticals and features 10 tablets arranged in two rows. The label includes prominently displayed product name, strength indication, and some dosage information, though finer text details are not fully legible.*

FDA Label Image

Figure (Dic05 0006 03)

Chemical structure of Diclofenac Sodium Delayed Release active ingredient, displayed as a ball-and-stick model with atoms colored by element and a 3D molecular arrangement.*

FDA Label Image

Figure (Dic05 0006 04)

Diclofenac Sodium Delayed Release 50 mg tablets packaging label by medsource pharmaceuticals. The box is primarily blue with white and orange accents. It features the product name, strength (50 mg), dosage form (tablets), and includes the product NDC 45865-999. The label indicates the product is a delayed release formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.